Place of Origin : Zhoushan,China

Crecoxib and rofexib are two specific inhibitors of cox-2 (cox-2) that are commonly used in clinical practice. Developed by GDSearle&Pfizer, USA, crecoxib was marketed in 1999 under the trade names Celebrex and Celebrex. This product has significant anti-inflammatory effects against Chemicalbook pain, with the lowest incidence of upper digestive tract ulcers and other complications.
Crecoxib is a non-steroidal anti-inflammatory drug, which plays an anti-inflammatory and analgesic role by inhibit